DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/3024fb/advanced_cancer_th) has announced the addition of Global Markets Direct's new companyprofile "Advanced Cancer Therapeutics - Product Pipeline Review - H2 2011" to their offering.
Global Market Direct's pharmaceuticals report, Advanced Cancer Therapeutics - Product Pipeline Review - H2 2011 provides data on the Advanced Cancer Therapeutics's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Advanced Cancer Therapeutics's corporate website, SEC filings, investor presentations and featured press releases, both from Advanced Cancer Therapeutics and industry-specific third party sources, put together by Global Markets Direct's team.
Scope
- Advanced Cancer Therapeutics - Brief Advanced Cancer Therapeutics overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Advanced Cancer Therapeutics human th
Key Topics Covered:
- List of Tables
- List of Figures
- Advanced Cancer Therapeutics Snapshot
- Advanced Cancer Therapeutics Overview
- Key Information
- Key Facts
- Advanced Cancer Therapeutics - Research and Development Overview
- Key Therapeutic Areas
- Advanced Cancer Therapeutics - Pipeline Review
- Pipeline Products by Stage of Development
- Pipeline Products - Monotherapy
- Advanced Cancer Therapeutics - Pipeline Products Glance
- Advanced Cancer Therapeutics Clinical Stage Pipeline Products
- Phase II Products/Combination Treatment Modalities
- Phase I Products/Combination Treatment Modalities
- Advanced Cancer Therapeutics - Early Stage Pipeline Products
- Pre-Clinical Products/Combination Treatment Modalities
- Advanced Cancer Therapeutics - Drug Profiles
- 3PO
- ACT-GRO-777
- CK37
- HPV Vaccine
- MIF
- PFK-015
- PU27
- Advanced Cancer Therapeutics - Pipeline Analysis
- Advanced Cancer Therapeutics - Pipeline Products by Therapeutic Class
- Advanced Cancer Therap
For more information visit http://www.researchandmarkets.com/research/3024fb/advanced_cancer_th